Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 30th, there was short interest totalling 5,500,000 shares, a decrease of 7.1% from the April 15th total of 5,920,000 shares. Based on an average daily trading volume, of 462,100 shares, the days-to-cover ratio […]

Related Keywords

Craig Hallum , Markl Baum , Surface Ophthalmics Inc , Harrow Inc , Ophir Asset Management Pty Ltd , Harrow Company Profile , Harrow Health Inc , Eton Pharmaceuticals Inc , Opaleye Management Inc , Securities Exchange Commission , Nasdaq , Pharmaceuticals Inc , Vanguard Group Inc , Capital Management , Get Free Report , Opaleye Management , Exchange Commission , Asset Management Pty Ltd , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Daily ,